Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 10/20 | 0.64 |
| ▸ | ABCC8 | Q09428 | 10/20 | 0.64 |
| ▸ | KCNJ11 | Q14654 | 10/20 | 0.64 |
| ▸ | KCNJ8 | Q15842 | 10/20 | 0.64 |
| ▸ | PDK1 | Q15118 | 11/20 | 0.60 |
| ▸ | PDK2 | Q15119 | 11/20 | 0.60 |
| ▸ | PDK3 | Q15120 | 11/20 | 0.60 |
| ▸ | PDK4 | Q16654 | 11/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11536864 | 0.86 | CYP1A2 (0.73) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| SCHEMBL9430839 | 0.85 | CYP1A2 (0.54) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| SCHEMBL5317682 | 0.82 | ABCC9 (0.74) | ABCC9ABCC8KCNJ11KCNJ8PDK1 | |
| SCHEMBL4058493 | 0.82 | ABCC9 (0.74) | ABCC9ABCC8KCNJ11KCNJ8PDK1 | |
| SCHEMBL5320042 | 0.81 | PDK1 (0.62) | ABCC9ABCC8KCNJ11KCNJ8PDK1 | |
| SCHEMBL5321364 | 0.80 | ABCC9 (0.57) | ABCC9ABCC8KCNJ11KCNJ8PDK1 | |
| SCHEMBL8866922 | 0.78 | ABCC9 (1.00) | ABCC9ABCC8KCNJ11KCNJ8CYP1A2 | |
| SCHEMBL1162352 | 0.77 | TDP1 (0.56) | CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10105366 | 0.77 | ALDH1A1 (0.56) | CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6108536 | 0.77 | MCHR1 (0.64) | CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007084614-A2 | HAIR GROWTH FORMULA | SAKURA PROPERTIES, LLC (US) | 2007-07-26 | — | — | WO | claimed |
| US-20060210515-A1 | HAIR GROWTH FORMULA | SAKURA PROPERTIES, LLC | 2006-09-21 | — | — | US | claimed |
| US-20030206935-A1 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | L'OREAL | 2003-11-06 | — | — | US | claimed |
| US-6602869-B1 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | L'OREAL S.A. (FR) | 2003-08-05 | — | — | US | claimed |
| EP-1169300-B1 | COMPOUNDS DERIVED FROM BENZOIC ACID ESTERS, COMPOSITION CONTAINING SAID COMPOUNDS AND USE THEREOF | OREAL (FR) | 2003-05-28 | — | — | EP | claimed |
| WO-2007084614-A2 | HAIR GROWTH FORMULA | SAKURA PROPERTIES, LLC (US) | 2007-07-26 | — | — | WO | disclosed |
| US-7125991-B2 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | L'OREAL S.A. (FR) | 2006-10-24 | — | — | US | disclosed |
| US-20060210515-A1 | HAIR GROWTH FORMULA | SAKURA PROPERTIES, LLC | 2006-09-21 | — | — | US | disclosed |
| US-20050101645-A1 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | GALEY JEAN-BAPTISTE (FR) | 2005-05-12 | — | — | US | disclosed |
| US-6844003-B2 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | L'OREAL (FR) | 2005-01-18 | — | — | US | disclosed |
| US-20030206935-A1 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | L'OREAL | 2003-11-06 | — | — | US | disclosed |
| US-6602869-B1 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | L'OREAL S.A. (FR) | 2003-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030206935-A1 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | CRAT, ETF1, BCOR | ABCC9 3156/4885ABCC8 2021/4885KCNJ11 2960/4885 |
| US-20050101645-A1 | Compounds derived from benzoic acid esters, composition containing said compounds and use thereof | HDAC7, RBBP7, KAT7 | ABCC9 2786/4885ABCC8 1452/4885KCNJ11 2571/4885 |
| US-20060210515-A1 | HAIR GROWTH FORMULA | HGF, HDGF, HGFAC | ABCC9 1980/4885ABCC8 951/4885KCNJ11 1304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.